InvestorsHub Logo
Followers 743
Posts 62142
Boards Moderated 11
Alias Born 10/05/2009

Re: sharp knife post# 639

Wednesday, 08/10/2011 11:49:43 PM

Wednesday, August 10, 2011 11:49:43 PM

Post# of 7747
They had a deal for several years with a European non profit trust that funded (paid them) for much of their earlier drug work, and they showed a profit 1 quarter per year based on that payment alone. Then in early 2008 they raised a bunch of cash, and bought RXII for almost nothing, then made a huge profit off selling it a bit at a time 2 years later. The test results on their pipelines have been incredible. I have high hopes of another partner deal funding one of their Phase III studies, on a shared revenue, or single drug buy out on performance plan, where most of the funding costs are paid by some one like NVS.

If you think Great depression II is on its way, do not buy this stock. If you think the risk of a recession now is overblown, and you have a high risk tolerance, this has a good risk/ reward ratio here. I first bought CYTR at about 33 cents in late 08 or early 09, and those shares went all the way to nearly $2/share. My mistake was I added shares at $1.33, and held long, never sold any, never traded, because I think there is a good chance the drugs in their pipeline will hit the jack pot. I was always afraid of sudden news of big deal coming out overnight, and it gapping way up at the open, and missing the boat.

These guys have demonstrated their skill at navigating real bad markets, and making profitable deals during them, so I am staying in and averaging down here, when I can.

Ambition with out knowledge is like ship in dry dock. Going nowhere fast!